Disposition of 165000 shares by Mark Schiller of Kezar Life at 2.28 subject to Rule 16b-3

KZR Stock  USD 6.58  0.17  2.52%   
Slightly above 62% of Kezar Life's investor base is looking to short. The analysis of the overall investor sentiment regarding Kezar Life Sciences suggests that many traders are alarmed. Kezar Life's investing sentiment overview a quick insight into current market opportunities from investing in Kezar Life Sciences. Many technical investors use Kezar Life Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Kezar Life Sciences Officer Chief Legal Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 165000 employee stock option (right to buy) at 2.28 of Kezar Life by Mark Schiller on 30th of June 2024. This event was filed by Kezar Life Sciences with SEC on 2024-01-15. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Kezar Life's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Kezar Life's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Kezar Life Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Kezar Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Kezar Life Fundamental Analysis

We analyze Kezar Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kezar Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kezar Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Kezar Life is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Kezar Life Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kezar Life stock to make a market-neutral strategy. Peer analysis of Kezar Life could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics with similar companies.

Peers

Kezar Life Related Equities

DSGNDesign Therapeutics   12.32   
0%
57.0%
FHTXFoghorn Therapeutics   3.96   
0%
18.0%
KROSKeros Therapeutics   3.13   
0%
14.0%
NRIXNurix Therapeutics   2.66   
0%
12.0%
MLYSMineralys Therapeutics,   2.18   
0%
10.0%
GLUEMonte Rosa   1.59   
0%
7.0%
SRZNSurrozen   1.52   
0%
7.0%
STOKStoke Therapeutics   1.49   
0%
6.0%
HOWLWerewolf Therapeutics   0.61   
0%
2.0%
CGEMCullinan Oncology   0.43   
0%
1.0%
LYELLyell Immunopharma   0.06   
0%
1.0%
KYMRKymera Therapeutics   0.00   
0%
0%
RVMDRevolution Medicines   0.67   
3.0%
0%
NKTXNkarta   1.28   
5.0%
0%
IKNAIkena Oncology   2.42   
11.0%
0%
BOLTBolt Biotherapeutics   2.83   
13.0%
0%
IPSCCentury Therapeutics   4.10   
19.0%
0%
STTKShattuck Labs   4.39   
20.0%
0%
LRMRLarimar Therapeutics   21.56   
100.0%
0%

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.